/Solventum%20Corp%20logo%20on%20phone-by%20Below%20the%20Sky%20via%20Shutterstock.jpg)
Based in Saint Paul, Minnesota, Solventum Corporation (SOLV) is an independent healthcare company. With a market cap of $12.7 billion, it develops and commercializes a range of products across Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration to meet critical healthcare and patient needs. SOLV is expected to release its fiscal Q3 earnings results after the market closes on Thursday, Nov. 7.
Ahead of this event, analysts expect the healthcare company to report a profit of $1.38 per share. The company has surpassed Wall Street's bottom-line estimates in the past two quarters. It exceeded the consensus EPS estimate by 6.9% in the most recent quarter. For fiscal 2024, analysts expect SOLV to report EPS of $6.38.